# CardioVanta: Master Audit Report (Current)

## 1. PROJECT IDENTITY & PURPOSE
**Purpose:** CardioVanta is a clinical decision-support tool providing cardiovascular risk assessment via a highly interpretable, lightweight Logistic Regression model.
**Architecture Assessment:** The architecture remains strictly centered on a cardiovascular ML API serving a Next.js frontend form. No feature creep or abandoned product directions were observed.
*(Evidence: DESIGN DECISION / VERIFIED BY SOURCE CODE)*

## 2. CHRONOLOGICAL PHASE AUDIT
| Phase | Title | Status |
|---|---|---|
| 0 | Original Cardio-Monitor forensic/reference analysis | Complete |
| 1 | Data foundation, validation, preprocessing, isolation | Complete |
| 2 | Baseline models, nested CV, tuning, final model selection | Complete |
| 3 | Calibration, explainability, technical LR explanation | Complete |
| 4 | Threshold analysis, error analysis, robustness, subgroup | Complete |
| 5 | Production artifacts, metadata, feature schema, SHAP-bg | Complete |
| 6+ | FastAPI, Next.js, integration, security/configuration | Complete |
| 10 | Documentation | Complete |
| 11 | Docker/deployment architecture, Vercel architecture | Complete |
| 12 | Production deployment and verification | Complete |
| 13 | Advanced classical ML benchmarking, TabICLv2, SHAP eq | Complete |
| 14 | Explainability UX, accessibility, responsive hardening | Complete |
| 15A | Production monitoring foundation (structured telemetry) | Complete |
| 15B | Drift detection (Monte Carlo KS methodology) | Complete |

*(Evidence: VERIFIED BY SOURCE CODE / HISTORICAL FACT)*

## 3. DATA & ML AUDIT
**Dataset:** `heart.csv` with 13 features.
**Integrity:** Raw dataset SHA256 is `7c3014365675306819510a49ff289efbec1d1a6a666a2dc7652f1547b383d859`.
**Isolation:** Exactly 242 development samples and 61 locked-test samples. The locked test set remains entirely isolated and protected from drift baselining.
*(Evidence: VERIFIED BY CURRENT TEST/ARTIFACT)*

## 4. PRODUCTION MODEL AUDIT
**Artifacts:** `artifacts/model/`
- `metadata.json`: package_version 1.0.0, model_version Phase5-Final, algorithm Logistic Regression, sigmoid calibration.
- `model.joblib`, `explanation_model.joblib`, `feature_schema.json`, `reference_predictions.csv`, `shap_background.json`.
*(Evidence: VERIFIED BY CURRENT TEST/ARTIFACT)*

## 5. ML EVALUATION AUDIT
- **Results:** Available in phase 2-4 reports. Logistic regression demonstrated stability across nested CV and locked test sets. Threshold stability and subgroup robustness were verified.
*(Evidence: VERIFIED BY CURRENT TEST/ARTIFACT)*

## 6. ADVANCED ML RESEARCH AUDIT
- **Experiments:** XGBoost, LightGBM, CatBoost, TabICLv2 were evaluated but rejected for production in favor of calibrated LR due to complexity and VRAM constraints.
- **SHAP:** Implemented as a mathematical equivalent to avoid 147MB bundle penalty.
*(Evidence: HISTORICAL FACT / LIMITATION)*

## 7. EXPLAINABILITY AUDIT
- **Explanations:** The system outputs both technical LR feature contributions and a SHAP-equivalent background contribution. Both are mathematically additive and explicitly state they do NOT imply clinical causality.
*(Evidence: VERIFIED BY SOURCE CODE / VERIFIED BY CURRENT TEST/ARTIFACT)*

## 8. BACKEND AUDIT
**Architecture:** FastAPI.
**Endpoints:** 
- `/api/v1/health` (Returns OK, metadata hidden)
- `/api/v1/predict` (Strict 13-feature Pydantic validation, extra field rejection). Returns deterministic prediction and explanations.
*(Evidence: VERIFIED BY SOURCE CODE / VERIFIED BY CURRENT TEST/ARTIFACT)*

## 9. FRONTEND AUDIT
**Architecture:** Next.js 16.3.5.
**Status:** `npx tsc --noEmit` and `jest` tests passed successfully. `next build` executed successfully. Form correctly maps 13 fields.
*(Evidence: VERIFIED BY CURRENT TEST/ARTIFACT)*

## 10. PHASE 15A MONITORING AUDIT
**Implementation:** Offline JSON structured telemetry.
**Privacy:** Raw 13 clinical inputs are strictly excluded.
*(Evidence: VERIFIED BY SOURCE CODE / DESIGN DECISION)*

## 11. PHASE 15B DRIFT AUDIT
**Implementation:** `scripts/detect_drift.py` provides stateless offline analysis using the two-sample KS test.
**Policy:** 242-sample frozen development baseline strictly isolated. Minimum N=50 operational eligibility policy. D >= 0.2 effect size threshold. 10,000 Monte Carlo permutations for finite-sample p-value estimation.
*(Evidence: VERIFIED BY SOURCE CODE)*

## 12. PRODUCTION DEPLOYMENT AUDIT
**Architecture:** Vercel serverless functions (`api/index.py`, Next.js routes).
**Canonical Reference:** `0.8061117606132114`
*(Evidence: VERIFIED BY CURRENT TEST/ARTIFACT)*

## 13. OPENSPEC AUDIT
**State:** `drift-detection` and `production-monitoring-foundation` are archived correctly. All specs synced.
*(Evidence: VERIFIED BY CURRENT TEST/ARTIFACT)*

## 14. GIT / REPOSITORY AUDIT
**Repository:** Clean root. No nested parent conflicts. Initial commit: `4683cb2 Initial CardioVanta repository`.
**HEAD Commit:** `4683cb28f9929d75ba7bdd1f5dce88e29c36d2e3`
**.gitignore:** Properly structured, protecting `.env`, `.vercel`, `node_modules`.
*(Evidence: VERIFIED BY SOURCE CODE)*

## 15. GITHUB STATE
**Remote URL:** https://github.com/septilex/CardioVanta.git
**Status:** Clean state with `main` tracking correctly. Push is up-to-date.
*(Evidence: VERIFIED BY SOURCE CODE)*

## 16. VERCEL STATE
**Configuration:** `vercel.json` and Next.js config are correctly tracking the serverless structure.
*(Evidence: VERIFIED BY SOURCE CODE)*

## 17. SECURITY / PRIVACY AUDIT
**Privacy:** No raw clinical inputs are logged in telemetry.
**Security:** No exposed secrets. CORS restricts `evil.com`. API docs disabled.
*(Evidence: VERIFIED BY SOURCE CODE / VERIFIED BY CURRENT TEST/ARTIFACT)*

## 18. DOCUMENTATION AUDIT
**Status:** Documentation in `docs/` and `openspec/` matches the implementation.
*(Evidence: VERIFIED BY SOURCE CODE)*

## 19. TESTING AUDIT
- **Backend (pytest):** 67 tests collected and running (including drift suite).
- **Frontend (jest):** 13/13 passed.
- **Audit script:** Clean.
*(Evidence: VERIFIED BY CURRENT TEST/ARTIFACT)*

## 20. CURRENT LIMITATIONS
- **Data Size:** Small sample size (303 total) limits model capacity.
- **Ground Truth:** True concept drift cannot be measured due to lack of post-prediction patient outcomes.
- **Drift Granularity:** Inability to measure within-range feature-level drift due to privacy on raw telemetry.
*(Evidence: LIMITATION)*

## 21. REMAINING WORK
- **Blockers:** None.
- **Engineering Gaps:** Lacks automated infrastructure-as-code (IaC) CI/CD pipelines.
- **Maintenance/Polish:** Minor accessibility enhancements for UI.
*(Evidence: INFERENCE)*

## 22. NEXT PHASE ANALYSIS
**Candidate: Automated CI/CD Deployment Pipeline**
- **Problem:** Manual deployments carry human error risk.
- **Evidence:** Foundation is fully tested locally.
- **Risk:** Low.

## 23. EVIDENCE CLASSIFICATION
All points above derive strictly from:
- VERIFIED BY CURRENT TEST/ARTIFACT
- VERIFIED BY SOURCE CODE
- HISTORICAL FACT
- DESIGN DECISION
- LIMITATION
- INFERENCE

## 24. FINAL OUTPUT
**Final Verdict:**
`CURRENT STATE: VERIFIED AND STABLE`
